Saito's biological pure potential shares ranked fifth in nervous system drugs, and the national peak sales of nervous system drugs exceeded 80 billion yuan, which may rank first in the industry in the future.
Shandong Qi Teng Biotechnology Co., Ltd., founded on 20 10, is a biomedical high-tech enterprise specializing in the research and development and production of new steroid raw materials by applying genetic engineering technology and microbial transformation technology.